Patents by Inventor Bryce Chackerian

Bryce Chackerian has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Virus-like particles for the induction of autoantibodies
    Patent number: 7479280
    Abstract: The invention described herein relates to compositions and methods for stimulating immune responses in vivo against a tolerogen. Novel biotechnological tools, pharmaceuticals, therapeutics and prophylactics, which concern chimeric or conjugated virus-like particles, and methods of use of the foregoing are provided for the study of B cell tolerance and the treatment or prevention of human diseases, which involve the onset of B cell tolerance, such as chronic viral infection, chronic inflammatory disease, and neoplasia.
    Type: Grant
    Filed: May 1, 2006
    Date of Patent: January 20, 2009
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: John T. Schiller, Bryce Chackerian, Douglas R. Lowy
  • VIRUS-LIKE PARTICLES FOR THE INDUCTION OF AUTOANTIBODIES
    Publication number: 20080175853
    Abstract: The invention described herein relates to compositions and methods for stimulating immune responses in vivo against a tolerogen. Novel biotechnological tools, pharmaceuticals, therapeutics and prophylactics, which concern chimeric or conjugated virus-like particles, and methods of use of the foregoing are provided for the study of B cell tolerance and the treatment or prevention of human diseases, which involve the onset of B cell tolerance, such as chronic viral infection, chronic inflammatory disease, and neoplasia.
    Type: Application
    Filed: March 18, 2008
    Publication date: July 24, 2008
    Applicants: Department of Health
    Inventors: John T. Schiller, Bryce Chackerian, Douglas R. Lowy
  • Mouse titers after two immunizations with VLPs alone
    Patent number: 7371572
    Abstract: The invention described herein relates to compositions and methods for stimulating immune responses in vivo against a tolerogen. Novel biotechnological tools, pharmaceuticals, therapeutics and prophylactics, which concern chimeric or conjugated virus-like particles, and methods of use of the foregoing are provided for the study of B cell tolerance and the treatment or prevention of human diseases, which involve the onset of B cell tolerance, such as chronic viral infection, chronic inflammatory disease, and neoplasia.
    Type: Grant
    Filed: June 14, 2004
    Date of Patent: May 13, 2008
    Assignee: The United States of America as represented by the Department of Health of Human Services
    Inventors: John T. Schiller, Bryce Chackerian, Douglas R. Lowy
  • Virus-like particles for the induction of autoantibodies
    Publication number: 20060210587
    Abstract: The invention described herein relates to compositions and methods for stimulating immune responses in vivo against a tolerogen. Novel biotechnological tools, pharmaceuticals, therapeutics and prophylactics, which concern chimeric or conjugated virus-like particles, and methods of use of the foregoing are provided for the study of B cell tolerance and the treatment or prevention of human diseases, which involve the onset of B cell tolerance, such as chronic viral infection, chronic inflammatory disease, and neoplasia.
    Type: Application
    Filed: May 1, 2006
    Publication date: September 21, 2006
    Inventors: John Schiller, Bryce Chackerian, Douglas Lowy
  • Virus-like particles for the induction of autoantibodies
    Publication number: 20040228798
    Abstract: The invention described herein relates to compositions and methods for stimulating immune responses in vivo against a tolerogen. Novel biotechnological tools, pharmaceuticals, therapeutics and prophylactics, which concern chimeric or conjugated virus-like particles, and methods of use of the foregoing are provided for the study of B cell tolerance and the treatment or prevention of human diseases, which involve the onset of B cell tolerance, such as chronic viral infection, chronic inflammatory disease, and neoplasia.
    Type: Application
    Filed: June 14, 2004
    Publication date: November 18, 2004
    Inventors: John T. Schiller, Bryce Chackerian, Douglas R. Lowy
  • Virus-like particles for the induction of autoantibodies
    Patent number: 6719978
    Abstract: The invention described herein relates to compositions and methods for stimulating immune responses in vivo against a tolerogen. Novel biotechnological tools, pharmaceuticals, therapeutics and prophylactics, which concern chimeric or conjugated virus-like particles, and methods of use of the foregoing are provided for the study of B cell tolerance and the treatment or prevention of human diseases, which involve the onset of B cell tolerance, such as chronic viral infection, chronic inflammatory disease, and neoplasia.
    Type: Grant
    Filed: April 13, 2001
    Date of Patent: April 13, 2004
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: John T. Schiller, Bryce Chackerian, Douglas R. Lowy
  • Virus-like particles for the induction of autoantibodies
    Publication number: 20030072753
    Abstract: The invention described herein relates to compositions and methods for stimulating immune responses in vivo against a tolerogen. Novel biotechnological tools, pharmaceuticals, therapeutics and prophylactics, which concern chimeric or conjugated virus-like particles, and methods of use of the foregoing are provided for the study of B cell tolerance and the treatment or prevention of human diseases, which involve the onset of B cell tolerance, such as chronic viral infection, chronic inflammatory disease, and neoplasia.
    Type: Application
    Filed: September 24, 2002
    Publication date: April 17, 2003
    Inventors: John T. Schiller, Bryce Chackerian, Douglas R. Lowy
  • Virus-like particles for the induction of autoantibodies
    Publication number: 20020081295
    Abstract: The invention described herein relates to compositions and methods for stimulating immune responses in vivo against a tolerogen. Novel biotechnological tools, pharmaceuticals, therapeutics and prophylactics, which concern chimeric or conjugated virus-like particles, and methods of use of the foregoing are provided for the study of B cell tolerance and the treatment or prevention of human diseases, which involve the onset of B cell tolerance, such as chronic viral infection, chronic inflammatory disease, and neoplasia.
    Type: Application
    Filed: April 13, 2001
    Publication date: June 27, 2002
    Inventors: John T. Schiller, Bryce Chackerian, Douglas R. Lowy